Oncotarget

Research Perspectives:

Cell fusion as a link between the SARS-CoV-2 spike protein, COVID-19 complications, and vaccine side effects

Yuri Lazebnik _

PDF  |  Full Text  |  How to cite  |  Order a Reprint

Oncotarget. 2021. [Epub ahead of print] https://doi.org/10.18632/oncotarget.28088

Metrics: PDF 12 views  |   Full Text 33 views  |   ?  


Abstract

Yuri Lazebnik1

1 Lerna Consulting, New Haven, CT 06511, USA

Correspondence to:

Yuri Lazebnik, email: yuri@lernaconsulting.com

Keywords: cell fusion; thrombosis; neuropathy; cancer; vaccines

Received: September 07, 2021     Accepted: September 24, 2021     Published: PUBLISHED_DATE

Copyright: © 2021 Lazebnik. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

ABSTRACT

A distinctive feature of the SARS-CoV-2 spike protein is its ability to efficiently fuse cells, thus producing syncytia found in COVID-19 patients. This commentary proposes how this ability enables spike to cause COVID-19 complications as well as side effects of COVID-19 vaccines, and suggests how these effects can be prevented.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 28088